Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,051 | 529 | 10,739 | 1,764 | 1,574 |
| Gross Profit | 1,051 | 529 | 10,739 | 1,764 | 1,574 |
| Operating Expenses | 6,341 | 9,188 | 9,251 | 27,463 | 15,507 |
| Operating Income | -5,290 | -8,659 | 1,488 | -25,699 | -13,933 |
| Interest Expense | 18 | 23 | 28 | 28 | 30 |
| Other Income | 1,552 | 940 | 1,063 | 1,201 | 1,431 |
| Pre-tax Income | -3,756 | -7,742 | 2,523 | -24,526 | -12,532 |
| Net Income Continuous | -3,756 | -7,742 | 2,523 | -24,526 | -12,532 |
| Net Income | $-3,756 | $-7,742 | $2,523 | $-24,526 | $-12,532 |
| EPS Basic Total Ops | -0.01 | -0.04 | 0.01 | -0.13 | -0.07 |
| EPS Basic Continuous Ops | -0.02 | -0.04 | 0.01 | -0.13 | -0.07 |
| EPS Diluted Total Ops | -0.01 | -0.04 | 0.01 | -0.13 | -0.07 |
| EPS Diluted Continuous Ops | -0.02 | -0.04 | 0.01 | -0.13 | -0.07 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.04 | 0.01 | -0.13 | -0.07 |
| EBITDA(a) | $-5,279 | $-8,648 | $1,499 | $-25,369 | $-13,600 |